|
PHF14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.275500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.937200E-03 |
| Normal-vs-Stage2 |
2.938600E-01 |
| Normal-vs-Stage3 |
2.909000E-01 |
| Normal-vs-Stage4 |
7.966300E-02 |
| Stage1-vs-Stage2 |
6.141600E-01 |
| Stage1-vs-Stage3 |
1.704960E-01 |
| Stage1-vs-Stage4 |
6.776000E-01 |
| Stage2-vs-Stage3 |
7.176400E-01 |
| Stage2-vs-Stage4 |
8.441600E-01 |
| Stage3-vs-Stage4 |
4.583000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.690120E-02 |
| Normal-vs-AfricanAmerican |
9.862800E-01 |
| Normal-vs-Asian |
4.233800E-02 |
| Caucasian-vs-AfricanAmerican |
8.260500E-02 |
| Caucasian-vs-Asian |
3.119400E-01 |
| AfricanAmerican-vs-Asian |
1.110410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.364270E-02 |
| Normal-vs-Female |
1.661980E-01 |
| Male-vs-Female |
2.402200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.735600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.683600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.361790E-02 |
| Normal-vs-Age(81-100Yrs) |
3.423800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.426200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.873800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.580200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.235600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.597400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.177060E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.152300E-02 |
| Normal-vs-Grade 2 |
6.759300E-03 |
| Normal-vs-Grade 3 |
1.345230E-01 |
| Normal-vs-Grade 4 |
3.671400E-01 |
| Grade 1-vs-Grade 2 |
4.135000E-01 |
| Grade 1-vs-Grade 3 |
1.404150E-01 |
| Grade 1-vs-Grade 4 |
1.880600E-01 |
| Grade 2-vs-Grade 3 |
1.294450E-01 |
| Grade 2-vs-Grade 4 |
2.146400E-01 |
| Grade 3-vs-Grade 4 |
8.252800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.152800E-04 |
| Normal-vs-ccB subtype |
2.278400E-01 |
| ccA subtype-vs-ccB subtype |
9.760500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.597900E-02 |
| Normal-vs-N1 |
5.254400E-01 |
| N0-vs-N1 |
9.285400E-01 |
|
|
